Skip to main content
Top
Published in: BMC Pediatrics 1/2020

Open Access 01-12-2020 | Biomarkers | Research article

Normative values for circulating intestinal fatty acid binding protein and calprotectin across gestational ages

Authors: Darla R. Shores, Jennifer Fundora, Mitzi Go, Fauzia Shakeel, Sandra Brooks, Samuel M. Alaish, Jun Yang, Chhinder P. Sodhi, David J. Hackam, Allen Everett

Published in: BMC Pediatrics | Issue 1/2020

Login to get access

Abstract

Background

Necrotizing enterocolitis (NEC) is associated with significant morbidity and mortality. Serum biomarkers to aid diagnosis, such as intestinal fatty acid binding protein (IFABP) and calprotectin, are actively being investigated; however, the normative values of these markers among healthy premature and term infants remains unknown. We sought to identify normative values for the serum concentrations of IFABP and calprotectin across gestational (GA) and post-menstrual age.

Methods

We collected serum from infants (24–40 weeks GA) in the first week of life and at multiple time points in a sub-cohort of premature infants (24–29 weeks GA), excluding sepsis or known intestinal disease. IFABP and calprotectin were measured using ELISA. Groups were compared with descriptive statistics and mixed effects linear regression.

Results

One hundred twelve infants had specimens in the first week of life, and 19 premature infants had longitudinal specimens. IFABP concentration in the first week of life was low and did not differ across gestational ages. Longitudinally, IFABP increased 4% per day (P < 0.001). Calprotectin concentration in the first week of life was more variable. An inverse relationship between day of life and calprotectin level was found in the longitudinal cohort (P < 0.001).

Conclusions

Serum IFABP and calprotectin fluctuate over time. Infants had low levels of IFABP during the first week of life, independent of gestational age, and levels increased longitudinally in premature infants. Calprotectin levels generally declined over time. Normative data for infants is necessary to establish meaningful cut-off levels for clinical use.
Literature
1.
go back to reference Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364(3):255–64.CrossRef Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364(3):255–64.CrossRef
2.
go back to reference Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA. 2015;314(10):1039–51.CrossRef Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA. 2015;314(10):1039–51.CrossRef
3.
go back to reference Fitzgibbons SC, Ching Y, Yu D, Carpenter J, Kenny M, Weldon C, et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg. 2009;44(6):1072–5 discussion 5–6.CrossRef Fitzgibbons SC, Ching Y, Yu D, Carpenter J, Kenny M, Weldon C, et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg. 2009;44(6):1072–5 discussion 5–6.CrossRef
4.
go back to reference Gosselin KB, Duggan C. Enteral nutrition in the Management of Pediatric Intestinal Failure. J Pediatr. 2014;165(6):1085–90.CrossRef Gosselin KB, Duggan C. Enteral nutrition in the Management of Pediatric Intestinal Failure. J Pediatr. 2014;165(6):1085–90.CrossRef
5.
go back to reference Pelsers MM, Namiot Z, Kisielewski W, Namiot A, Januszkiewicz M, Hermens WT, et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem. 2003;36(7):529–35.CrossRef Pelsers MM, Namiot Z, Kisielewski W, Namiot A, Januszkiewicz M, Hermens WT, et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem. 2003;36(7):529–35.CrossRef
6.
go back to reference Thuijls G, Derikx JP, van Wijck K, Zimmermann LJ, Degraeuwe PL, Mulder TL, et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg. 2010;251(6):1174–80.CrossRef Thuijls G, Derikx JP, van Wijck K, Zimmermann LJ, Degraeuwe PL, Mulder TL, et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg. 2010;251(6):1174–80.CrossRef
7.
go back to reference Cronk DR, Houseworth TP, Cuadrado DG, Herbert GS, McNutt PM, Azarow KS. Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small bowel obstruction. Curr Surg. 2006;63(5):322–5.CrossRef Cronk DR, Houseworth TP, Cuadrado DG, Herbert GS, McNutt PM, Azarow KS. Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small bowel obstruction. Curr Surg. 2006;63(5):322–5.CrossRef
8.
go back to reference Reisinger KW, Elst M, Derikx JP, Nikkels PG, de Vries B, Adriaanse MP, et al. Intestinal fatty acid-binding protein: a possible marker for gut maturation. Pediatr Res. 2014;76(3):261–8.CrossRef Reisinger KW, Elst M, Derikx JP, Nikkels PG, de Vries B, Adriaanse MP, et al. Intestinal fatty acid-binding protein: a possible marker for gut maturation. Pediatr Res. 2014;76(3):261–8.CrossRef
9.
go back to reference Gregory KE, Winston AB, Yamamoto HS, Dawood HY, Fashemi T, Fichorova RN, et al. Urinary intestinal fatty acid binding protein predicts necrotizing enterocolitis. J Pediatr. 2014;164(6):1486–8.CrossRef Gregory KE, Winston AB, Yamamoto HS, Dawood HY, Fashemi T, Fichorova RN, et al. Urinary intestinal fatty acid binding protein predicts necrotizing enterocolitis. J Pediatr. 2014;164(6):1486–8.CrossRef
10.
go back to reference Yang G, Wang Y, Jiang X. Diagnostic value of intestinal fatty-acid-binding protein in necrotizing Enterocolitis: a systematic review and meta-analysis. Indian J Pediatr. 2016;83(12–13):1410–9.CrossRef Yang G, Wang Y, Jiang X. Diagnostic value of intestinal fatty-acid-binding protein in necrotizing Enterocolitis: a systematic review and meta-analysis. Indian J Pediatr. 2016;83(12–13):1410–9.CrossRef
11.
go back to reference Terrin G, Stronati L, Cucchiara S, De Curtis M. Serum Markers of Necrotizing Enterocolitis: A Systematic Review. J Pediatric Gastroenterol Nutri. 2017;65(6):e120–e132.CrossRef Terrin G, Stronati L, Cucchiara S, De Curtis M. Serum Markers of Necrotizing Enterocolitis: A Systematic Review. J Pediatric Gastroenterol Nutri. 2017;65(6):e120–e132.CrossRef
12.
go back to reference Cheng S, Yu J, Zhou M, Tu Y, Lu Q. Serologic intestinal-fatty acid binding protein in necrotizing Enterocolitis diagnosis: a meta-analysis. Biomed Res Int. 2015;2015:156704.PubMedPubMedCentral Cheng S, Yu J, Zhou M, Tu Y, Lu Q. Serologic intestinal-fatty acid binding protein in necrotizing Enterocolitis diagnosis: a meta-analysis. Biomed Res Int. 2015;2015:156704.PubMedPubMedCentral
13.
go back to reference Ho SSC, Keenan JI, Day AS. The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal Diseases. Dig Dis Sci. 2020;65(2):376–90.CrossRef Ho SSC, Keenan JI, Day AS. The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal Diseases. Dig Dis Sci. 2020;65(2):376–90.CrossRef
14.
go back to reference Zoppelli L, Guttel C, Bittrich HJ, Andree C, Wirth S, Jenke A. Fecal calprotectin concentrations in premature infants have a lower limit and show postnatal and gestational age dependence. Neonatology. 2012;102(1):68–74.CrossRef Zoppelli L, Guttel C, Bittrich HJ, Andree C, Wirth S, Jenke A. Fecal calprotectin concentrations in premature infants have a lower limit and show postnatal and gestational age dependence. Neonatology. 2012;102(1):68–74.CrossRef
15.
go back to reference Kapel N, Campeotto F, Kalach N, Baldassare M, Butel MJ, Dupont C. Faecal calprotectin in term and preterm neonates. J Pediatr Gastroenterol Nutr. 2010;51(5):542–7.CrossRef Kapel N, Campeotto F, Kalach N, Baldassare M, Butel MJ, Dupont C. Faecal calprotectin in term and preterm neonates. J Pediatr Gastroenterol Nutr. 2010;51(5):542–7.CrossRef
16.
go back to reference Schurink M, Kooi EM, Hulzebos CV, Kox RG, Groen H, Heineman E, et al. Intestinal fatty acid-binding protein as a diagnostic marker for complicated and uncomplicated necrotizing enterocolitis: a prospective cohort study. PLoS One. 2015;10(3):e0121336.CrossRef Schurink M, Kooi EM, Hulzebos CV, Kox RG, Groen H, Heineman E, et al. Intestinal fatty acid-binding protein as a diagnostic marker for complicated and uncomplicated necrotizing enterocolitis: a prospective cohort study. PLoS One. 2015;10(3):e0121336.CrossRef
17.
go back to reference Terrin G, Passariello A, Manguso F, Salvia G, Rapacciuolo L, Messina F, et al. Serum calprotectin: an antimicrobial peptide as a new marker for the diagnosis of sepsis in very low birth weight newborns. Clin Dev Immunol. 2011;2011:291085.CrossRef Terrin G, Passariello A, Manguso F, Salvia G, Rapacciuolo L, Messina F, et al. Serum calprotectin: an antimicrobial peptide as a new marker for the diagnosis of sepsis in very low birth weight newborns. Clin Dev Immunol. 2011;2011:291085.CrossRef
Metadata
Title
Normative values for circulating intestinal fatty acid binding protein and calprotectin across gestational ages
Authors
Darla R. Shores
Jennifer Fundora
Mitzi Go
Fauzia Shakeel
Sandra Brooks
Samuel M. Alaish
Jun Yang
Chhinder P. Sodhi
David J. Hackam
Allen Everett
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Biomarkers
Published in
BMC Pediatrics / Issue 1/2020
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-020-02142-5

Other articles of this Issue 1/2020

BMC Pediatrics 1/2020 Go to the issue